CONCENTRIX CORP's ticker is CNXC and the CUSIP is 20602D101. A total of 357 filers reported holding CONCENTRIX CORP in Q1 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $288 | -8.9% | 4,555 | -4.4% | 0.00% | 0.0% |
| Q1 2024 | $316 | -32.5% | 4,767 | 0.0% | 0.00% | -50.0% |
| Q4 2023 | $468 | -13.7% | 4,767 | -51.3% | 0.00% | +100.0% |
| Q3 2023 | $542 | +16.3% | 9,780 | +69.3% | 0.00% | -50.0% |
| Q2 2023 | $466 | -33.6% | 5,776 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $702 | -8.7% | 5,776 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $769 | -99.9% | 5,776 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $645,000 | -17.6% | 5,776 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $783,000 | -18.6% | 5,776 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $962,000 | -14.0% | 5,776 | -7.7% | 0.00% | -20.0% |
| Q4 2021 | $1,118,000 | +0.9% | 6,260 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $1,108,000 | +10.0% | 6,260 | 0.0% | 0.01% | +25.0% |
| Q2 2021 | $1,007,000 | +7.5% | 6,260 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $937,000 | +51.6% | 6,260 | 0.0% | 0.00% | +33.3% |
| Q4 2020 | $618,000 | – | 6,260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Groupe Bruxelles Lambert | 8,773,667 | $555,197,648 | 100.00% |
| Impactive Capital LP | 3,846,370 | $243,398,294 | 9.46% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 623,542 | $39,457,738 | 1.80% |
| LYRICAL ASSET MANAGEMENT LP | 1,271,250 | $80,444,700 | 1.29% |
| Copeland Capital Management, LLC | 985,722 | $62,376,533 | 1.17% |
| Nierenberg Investment Management Company, Inc. | 27,910 | $1,766,145 | 0.99% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 564,732 | $35,736,207 | 0.97% |
| VALLEY WEALTH MANAGERS, INC. | 168,482 | $10,661,541 | 0.85% |
| Bragg Financial Advisors, Inc | 202,698 | $12,826,730 | 0.57% |
| CLARK ESTATES INC/NY | 44,250 | $2,800,140 | 0.53% |